Clinical Trial: Entinostat in Combination with CDK4/6 Inhibitors and Endocrine Therapy: A Single-Arm, Exploratory Phase II Clinical Trial in Patients with Treatment-Naïve Advanced HR+/HER2-Negative Breast Cancer (China)

China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Entinostat in Combination with CDK4/6 Inhibitors and Endocrine Therapy: A Single-Arm, Exploratory Phase II Clinical Trial in Patients with Treatment-Naïve Advanced HR+/HER2-Negative Breast Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132757

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: HenanCancerHospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333253

Published by HT Digital Content Services with permission from Health Daily Digest....